HR+ mBC: CDK4/6i Progression Management
By
Stanford Medicine
FEATURING
Milana Dolezal
By
Stanford Medicine
FEATURING
Milana Dolezal
Check out related topics by Dr. Dolezal:
1) ADCs in HR+ Advanced/Metastatic BC
2) HR+ Advanced/Metastatic BC Treatment Options: Refining Endocrine Sensitivity
1) ADCs in HR+ Advanced/Metastatic BC
2) HR+ Advanced/Metastatic BC Treatment Options: Refining Endocrine Sensitivity
Comments 0
Login to view comments.
Click here to Login
